ELEKTROFI
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience. Elektrofi’s formulation system can effectively process a wide range of therapeutic molecules. Their technology has the capacity to process large, increasingly complex and delicate proteins including monoclonal antibodies, bispecifics and fusion proteins. Founded in 2016, Elektrofi is based in Boston, Massachusetts, United States.
ELEKTROFI
Industry:
Alternative Medicine Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.elektrofi.com
Total Employee:
11+
Status:
Active
Contact:
866-610-2683
Email Addresses:
[email protected]
Total Funding:
41.86 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Typekit
Similar Organizations
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Marshall Wace
Marshall Wace investment in Series B - Elektrofi
BVF Partners
BVF Partners investment in Series B - Elektrofi
Logos Capital
Logos Capital investment in Series B - Elektrofi
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Elektrofi
National Science Foundation
National Science Foundation investment in Grant - Elektrofi
National Science Foundation
National Science Foundation investment in Grant - Elektrofi
Official Site Inspections
http://www.elektrofi.com Semrush global rank: 1.34 M Semrush visits lastest month: 21.66 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
